Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
Check source scope before reading a dose
UCSF remdesivir - renal and dialysis protocols
Product / population
Adult COVID-19 treatment with intravenous remdesivir. Pediatric weight-based dosing is excluded.
Renal method
CrCl mL/min; IHD and continuous hemodialysis
Source revision
Revision date not stated on the reviewed page.
Retrieved
2026-09-05
Local review status
Separate professional-source protocol; not automatically equivalent to product labeling.
University of California San Francisco (UCSF) · Adult COVID-19 treatment with intravenous remdesivir. Pediatric weight-based dosing is excluded.
Renal method: CrCl mL/min; IHD and continuous hemodialysis Source date: Revision date not stated on the reviewed page. Retrieved: 2026-09-05
Separate professional-source protocol; not automatically equivalent to product labeling.
Source-specific renal protocol
UCSF gives 200 mg IV once, then 100 mg every 24 hours for both renal-function columns and for intermittent/continuous hemodialysis. Its CrCl-below-30 column adds a vehicle-accumulation risk/benefit caution without reducing the dose.
RDM31-remdesivir-prof-1 · Source locator: Adult non-dialysis and intermittent/continuous hemodialysis tables
Source-specific limits
The printed non-dialysis headings use >30 and <30, omitting exact 30. The selected U.S. label explicitly permits the same dosing at all renal-function levels. Do not treat the institutional vehicle note as a labeled contraindication.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh v6.6 | RDM66-DIRECT-PHP-20260911 | Local library date 2026-09-11. Selected-card identity does not imply clinical verification.